you are here: Home News Glenmark

Glenmark

Glenmark Standalone March 2025 Net Sales at Rs 2,009.49 crore, down 6.46% Y-o-Y
Glenmark Consolidated December 2024 Net Sales at Rs 3,387.55 crore, up 35.14% Y-o-Y
Aurobindo Pharma, Glenmark recall products in US
Glenmark Consolidated September 2024 Net Sales at Rs 3,433.80 crore, up 7.06% Y-o-Y
Glenmark Standalone September 2024 Net Sales at Rs 2,636.10 crore, up 18.03% Y-o-Y
Glenmark Pharmaceuticals PAT at Rs 354 crore in September quarter
Domestic formulations biz expected to grow 9-10% over next decade: Glenmark
Glenmark Consolidated June 2024 Net Sales at Rs 3,244.19 crore, down 4.63% Y-o-Y
Glenmark Standalone June 2024 Net Sales at Rs 2,329.54 crore, up 8.63% Y-o-Y
Glenmark Consolidated March 2024 Net Sales at Rs 3,062.95 crore, down 9.21% Y-o-Y
Glenmark Standalone March 2024 Net Sales at Rs 2,148.22 crore, up 10.79% Y-o-Y
Glenmark Pharma Q4 net loss widens to Rs 1,239 crore
Glenmark unit ties up with BeiGene to market cancer drugs in India
Glenmark gets USFDA nod for generic ophthalmic solution
Lupin, Glenmark recall drugs in US market: USFDA
Lupin, Glenmark, Natco recall products from US markets
Glenmark Consolidated December 2023 Net Sales at Rs 2,506.70 crore, down 27.63% Y-o-Y
Glenmark Standalone December 2023 Net Sales at Rs 1,365.10 crore, down 36.84% Y-o-Y
Nirma Rs 1,343 crore open offer to buy more stake in Glenmark Life Sciences to start on Feb 15
Glenmark, Sun Pharma recall drugs in the US over labelling and manufacturing concerns, confirms USFDA
Dr Reddy's, Glenmark recall products in US due to manufacturing issues
Glenmark Standalone September 2023 Net Sales at Rs 2,233.42 crore, up 1.14% Y-o-Y
Glenmark Consolidated June 2023 Net Sales at Rs 3,401.60 crore, up 22.48% Y-o-Y
Glenmark Standalone June 2023 Net Sales at Rs 2,144.38 crore, up 12.16% Y-o-Y
Lupin may spin off API business as part of business recast to unlock value

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Glenmark

Glenmark Standalone March 2025 Net Sales at Rs 2,009.49 crore, down 6.46% Y-o-Y

Glenmark Consolidated December 2024 Net Sales at Rs 3,387.55 crore, up 35.14% Y-o-Y

Aurobindo Pharma, Glenmark recall products in US

Glenmark Consolidated September 2024 Net Sales at Rs 3,433.80 crore, up 7.06% Y-o-Y

Glenmark Standalone September 2024 Net Sales at Rs 2,636.10 crore, up 18.03% Y-o-Y

Glenmark Pharmaceuticals PAT at Rs 354 crore in September quarter

Domestic formulations biz expected to grow 9-10% over next decade: Glenmark

Glenmark Consolidated June 2024 Net Sales at Rs 3,244.19 crore, down 4.63% Y-o-Y

Glenmark Standalone June 2024 Net Sales at Rs 2,329.54 crore, up 8.63% Y-o-Y

Glenmark Consolidated March 2024 Net Sales at Rs 3,062.95 crore, down 9.21% Y-o-Y

Glenmark Standalone March 2024 Net Sales at Rs 2,148.22 crore, up 10.79% Y-o-Y

Glenmark Pharma Q4 net loss widens to Rs 1,239 crore

Glenmark unit ties up with BeiGene to market cancer drugs in India

Glenmark gets USFDA nod for generic ophthalmic solution

Lupin, Glenmark recall drugs in US market: USFDA

Lupin, Glenmark, Natco recall products from US markets

Glenmark Consolidated December 2023 Net Sales at Rs 2,506.70 crore, down 27.63% Y-o-Y

Glenmark Standalone December 2023 Net Sales at Rs 1,365.10 crore, down 36.84% Y-o-Y

Nirma Rs 1,343 crore open offer to buy more stake in Glenmark Life Sciences to start on Feb 15

Glenmark, Sun Pharma recall drugs in the US over labelling and manufacturing concerns, confirms USFDA

Dr Reddy's, Glenmark recall products in US due to manufacturing issues

Glenmark Standalone September 2023 Net Sales at Rs 2,233.42 crore, up 1.14% Y-o-Y

Glenmark Consolidated June 2023 Net Sales at Rs 3,401.60 crore, up 22.48% Y-o-Y

Glenmark Standalone June 2023 Net Sales at Rs 2,144.38 crore, up 12.16% Y-o-Y

Lupin may spin off API business as part of business recast to unlock value